Observational studyThe oncologist2025

Enhancing the interpretation of real-world quality of life in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer enrolled in the POLARIS study.

Gabrielle B Rocque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.